Houston Methodist cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis, and also monitor disease progression and response to therapy in real time.
The discovery of identifying a distinct group of cells in the bloodstream of patients who have breast cancer brain metastases could lead to the creation of more sensitive screening tools.
In the Aug. 4 online issue of Nature Communications, a proof-of-concept study led by Dario Marchetti, Ph.D., detected a distinct group of circulating tumor cells (CTCs) associated with brain metastasis. The finding brings cancer researchers closer to understanding how the “seeds” of metastatic disease can thrive in breast cancer patients and cause it to spread to the brain.
“Our research confirmed that CTCs in breast cancer brain metastases are distinct from other circulating tumor cells. Moreover, unlocking the mystery of how these seeds of metastatic disease survive and thrive over a period of years, sometimes decades, is an enigma in cancer,” said Marchetti, senior author and director of the Biomarker Research Program at Houston Methodist Research Institute. “Now we can take this information and develop a more sensitive screening tool to detect metastatic cancer in the blood, possibly even before metastasis is radiologically detectable by MRI.”
Magnetic resonance imaging is the accepted standard-of-care to diagnose breast cancer brain metastasis (BCBM) in patients. However, in most cases, by the time MRI detects the metastatic mass, the cancer has progressed to a stage where few curative treatment options are available, leading to poor overall survival. According to extensive clinical studies, approximately 20 percent of breast cancer patients will develop brain metastasis over their lifetime, and, in general, metastatic disease to the brain is estimated to become the number one cancer killer within the next decade.
“Our lab is the first in this field to perform a comprehensive report of patient-derived circulating tumor cells at the gene expression level, so we now have a clearer picture of the signaling pathways that allows them to establish brain metastases. By comparing the whole genome expression patterns of CTCs isolated from patient blood samples diagnosed with or without BCBM, we uncovered a 126 gene-signature that is specific to these brain metastatic CTCs,” said Debasish Boral, Ph.D., the paper’s first author and a research associate with the Biomarker Research Program at Houston Methodist Research Institute.
This research builds on a 2015 research paper where Marchetti’s lab isolated four distinct circulating tumor cell subsets that were implicated in breast cancer cell dormancy. Viable breast cancer cells can remain dormant in the patients’ bone marrow or other organs like the brain, lungs and liver, even decades after a primary tumor is surgically removed. These scattered cells are often undetectable by traditional clinical tools, making it nearly impossible to detect and treat metastatic disease while still amenable to therapy.
The Houston Methodist researchers are now focused on broadening the study patient population, with the end goal of transforming this information into the development of two kinds of non-invasive liquid biopsies that could be used by treating physicians: a screening method to predict brain metastasis before the disease is detectable by current diagnostic standards (MRI); and another to monitor treatment efficacy in real-time in those patients diagnosed with brain metastasis.
Other researchers collaborating on the Nature Communications paper were: Monika Vishnoi, Haowen N. Liu, Wei Yin, and Marc L. Sprouse (Houston Methodist Research Institute, Houston, TX); Jenny C. Chang (Houston Methodist Hospital, Houston, TX); Antonio Scamardo and David S. Hong (The University of Texas MD Anderson Cancer Center, Houston, TX); and Tuan Z. Tan and Jean P. Thiery (Cancer Science Institute of Singapore, National University of Singapore).
To speak with Dario Marchetti, Ph.D., contact Lisa Merkl, Houston Methodist, at 832-667-5916 or firstname.lastname@example.org. For more information about Houston Methodist, visit houstonmethodist.org. Follow us on Twitter and Facebook.
For more information: Molecular characterization of breast cancer CTCs associated with brain metastasis. Nature Communications DOI: 10.1038/s41467-017-00196-1. (Online Aug. 4, 2017) D. Boral, M. Vishnoi, H. N. Liu, W. Yin, M. L. Sprouse, A. Scamardo, D. S. Hong, T. Z. Tan, J. P. Thiery, J. C. Chang, and D. Marchetti.
Baylor College of MedicineBaylorCollegeOfMedicine
Dr. Jeanine Graf discusses how the expansion of Texas Children’s Hospital-Katy campus will enhance pediatric health services.
The @aao_ophth and @AAS_Office offer these five tips for viewing the eclipse: https://t.co/MkZ3nYR23n #texaschildrens
Texas A&M University Health Science CenterTAMUhealthsciences
“Sit-stand desks have been shown to increase physical activity in the workplace, yet most studies show a reduction in utilization over time."
U.S. Department of Veterans AffairsVeteransAffairs
Did you know some VA benefits have deadlines? Learn how to look up VA benefits you may be eligible to receive during our Facebook Live event August 22 at 2 p.m....
Texas Children's HospitalTexasChildrensHospital
Are you planning to watch on Monday? Follow these five tips to safely view the eclipse:
?It was a gift because it was all the things she had to sacrifice.? https://t.co/GrZPfUTf1X @TODAYshow @jennabushhager #endcancer
New GI Bill signed, expanding college assistance for Veterans https://t.co/Kz9r9VHNZO via @washingtonpost
Watch LIVE below as Dr. Pamela Berens, an OB/GYN and lactation expert with McGovern Medical School and Children's Memorial Hermann Hospital, discusses breastfee...
.@CPRITTexas awards MD Anderson $7.5 million for #cancer research and facility support: https://t.co/D7hrqnI6dN #endcancer
RT @BCMHouston_News: .@CPRITTexas grant helps bring outstanding #cancer researcher to @bcmhouston. Read more @ChronMed @HoustonChron https:?
This guy is too cool for school. Read more about this #tbt on our blog: https://t.co/zk41O8sB1Q https://t.co/Mioeh96sbg
Baylor College of MedicineBaylorCollegeOfMedicine
This guy is too cool for school. Read more about this #tbt on our blog: http://bit.ly/2ia89nJ
@SergioT_02 Welcome to Texas... in August! We get it. We'll have water available @ stations across campus next week? https://t.co/KrW4jEKWWU
TAMU Health Sciences@TAMHSC
#TAMHSC researchers are examining ways to enhance and sustain the use of the sit-stand desk. https://t.co/4gkXBdmYB4 #Ergonomics
Did you see our 2021 class photo? ? #RiceOWeek17 https://t.co/Gg8mwR7Wup